Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ensysce Biosciences (ENSC) Depreciation & Amortization (CF) (2020 - 2021)

Historic Depreciation & Amortization (CF) for Ensysce Biosciences (ENSC) over the last 2 years, with Q3 2021 value amounting to $50.0.

  • Ensysce Biosciences' Depreciation & Amortization (CF) changed 0.0% to $50.0 in Q3 2021 from the same period last year, while for Jun 2022 it was $50.0, marking a year-over-year decrease of 7536.95%. This contributed to the annual value of $151.0 for FY2021, which is 2487.56% down from last year.
  • According to the latest figures from Q3 2021, Ensysce Biosciences' Depreciation & Amortization (CF) is $50.0, which was down 0.0% from $50.0 recorded in Q2 2021.
  • In the past 5 years, Ensysce Biosciences' Depreciation & Amortization (CF) registered a high of $52.0 during Q4 2020, and its lowest value of $50.0 during Q2 2020.